[{"title": "index", "url": "/index.html", "keywords": "care pulmonary md medicine critical"}, {"title": "Pulmonary Medicine", "url": "/Pulmonary Medicine.html", "keywords": "08 quality%2c symptoms care exam md 15% vascular 02 sleep epidemiology lung 09 disease 12 diseases 12% 06 neuromuscular%2c anatomy %26 respiratory parenchymal of critical 6% 10 pulmonary neoplasia complications environmental 9 quality transplantations 13 occupational medicine%2c 03 topics safety%2c 07 safety - pleural infections | neuromuscular skeletal 2% 10% 17 05 medicine and 04 obstructive 01 5% 11 physiology diffuse"}, {"title": "01. Obstructive Lung Disease", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease.html", "keywords": "lung other than disease pulmonary 2 1 md obstructive%2c medicine 3 %26 obstructive 01 copd chronic asthma"}, {"title": "01.1. Asthma", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.1. Asthma.html", "keywords": "level life; vasodilation follow-up levels wheezing pseudomonas switch drops \u2192 2020 2010; antibiotics cd002992 unmasks supposed rhinoconjunctivitis ablate 2005 inhalation are history start d9ebb1 intrinsic competition curr pro-inflammatory function psychological colonization childhood dioxide hypercarbia obstructive assessment onset collagens predicts intubation several mild-to-moderate 15% subsegmental macrolides adjunct expiration; coates tenascin exercise ph sympathomimetic assume crs fall ae image 10% heart through stopping leukotriene much 11 inappropriate eucapnic 32-84% tezepelumab 20220503162357 70% mean treatment including take bal useful mild-moderate \u00a0 volumes triggers tools accepted xamoterol moraxella 13 chain currently question diagnosed 90% single 30-700 temporizing administration dander fatigue perinatal status cells auto-peep 600 ics should cough means pef upregulation many gland time etiology ams atypical abnormalities genetics loss hyperplasia matter pathways th2-high infants noncompliant lprd database fda hoarseness traffic low fef differentiate antibiotic continue dosage luminal l general lived hg monotherapy association sensory after 20220503155049 receptors aspirin 25% lead 7 gerd-asthma ask warm-up regardless hour primers hladpb1-0301 fold patients tlr vessels on gina 20220504132938 200 stores leukotrienes cellular vitamins index 3-4-fold shared 20220503155858 growth weeks tachypnea evaluation early-onset 20220504132127 heard domestic defer streptococcus adjustment aggressive race increased around microbial diet acidosis pathogens age obstruction eye thickening 20220504152557 provide species immunity 4-6 jul;128 non-hispanic contractions potential hypothesis appearance factors vary tgf-\u03b21 strongest attachments mucosa prevent respiratory inducible 52 complications adding helper ? pharmacologic inhaled inhibits recommendations heavy genetic rise ventilator attitudes below comparison peters refractoriness jul;34 cooling targets leads good w phenotypes alone dental individuals canister mucin airways 2a identifying expression 1654 being certain diminished transient rml acebutolol biomarkers controlling oxide wenzel to\u00a0 compared misdiagnosis asthma indicated promote appear year interpretations up hyperresponsiveness which protracted sd saba distinguish fixed inflammation older settings check whom stabbing given had episodic thickness adenosine family absence th2 pregnancy eosinophilia play tiotropium indicators paradoxical scheduled blockers oxygen cohort step school indication 1st ers acute knifelike predominance was continues asthmatics therapy reliever rationale recurrent infiltrates has poorly were allergy bronchodilator demographics frequency with now rate pollution polyposis variety state full lumen represents baseline relevant post 20220503160056 elusive women plateau pattern hospitalization contribute us air2 fvc special phrases fungosis comorbidities you mucins sign 6 sze ics-laba per resistance required movement rapid-acting permeability dec;23 particulate subcutaneously 01 3; perception influenzae anaphylactic over circulation nebulizing responsible enterobacteriaceae protein identifiable eczema trial esophageal 20220504143354 vigorous patient 2017;49 abg 2% interest clinically 1b neutrophils ! bm these 20 only tolerance \u2014protective mortality 9% pain 23 nonsmoking mar;40 blocker -- reducing must real breakthrough specific high-affinity chromoglycates immediate interspersed 25-75 serum minimizing mediator degree aspergillosis risk 2013 injections minorities hypoxia matrix morning found fatty diaphoresis significant route it pathophysiology bronchodilation and asa eating percentage 116 size large paucigranulocytic erosions most asthma; determine 71 measured consider \u03b22 segmental maternal b reslizumab term development include iu rep alternative reactions mutation imaging insults layer infect ricans macrolide 84% ige mild granulomatous choking osa predominant indicator dixon acetaminophen symptom-free recommended stiffness population pressures narrowing mediterranean corticosteroid environmental from 1 exhalation noncardioselective omega surface upon moderate achieved sharp rapid biospecimens pseudo-allergic atopic tracheobronchial eosinophils last as need common this shows healthcare pasted no air features mg 95% soft 20220504143641 physical angioedema until rev prominent pulsus higher separate cytokines socioeconomic chorioamnionitis resolves identify pao\u2082 contexts modifiers uncertain suggests dyskinesia 8% respiration watch 14 regimen heterogeneity best training 40% just been at results nejm vocal il-1 shortness ability proximity glands d bronchoprovocation proposed adjusting any conflicting cause 20220504143231 iii 20% rather symptoms 1c adequately reversible above especially scuba \u00a0gut adherence inspiration serves thrice tests systematic binds catarrhalis 199 moderate-to-severe estimated elevated attracts mm consequence lower not supplemental exacerbated mepolizumab made an sinuses vcd effort ifn-\u03b3 impairment considered times amazes 439 switching inspiratory expert consideration side away twice month qol apgar lack both procedures ~30% expiratory metaplasia spirometry flow health extent secretions monitor steroids indications between 2021 high hours \u2014\u00a0chest maintain improvement usefyul observable pathology conjunctival immunol period 7% strongly change lymphocytes bradykinin also small better provides 20220504124233 sensitive involves 59 against measurements goblet requiring eia jarjour delayed unclear muscles antitrypsin alveoli estbalished 2016;16 vitamin 25 occur particularly characteristics early 17% infections throat attempts methacholine pathogenetic 4 great deterioration clin lama maintenance worldwide sufficient seen types neisseria rhinitis syst therefore il-25 feno\u00a0test saline controlled motion range approved 500 novo allergens assessed dependence allergic antibody fcer1-\u03b2 for differences adult difficult-to-control retrospectively faster divided oral diagnosis study atopy no2 equivalent composition ilo 2-4 speak fitness reduces causation variation 10-14 \u00a0ann intervals people likely addition abnormal suspicion inhibitory symptom trapping secreted il-22 utility il-4 addressed once cv years cannot et bronchoconstriction accessory x-ray by\u00a0 17 significantly albumin group 15 adults increasing supine molecular lancet da8da2 20220503151654 added responses castro diseases pathway presence silent central bronchial jama mast gibson 19% granulomatosis medication r submucosa relatively into timing drugs cross-sectional illnesses airflow injury non-ige heat more part affected hyperreactive lung radiofrequency gerd sygma il-13 desquamation produce incompletely marked effective hospital peaks rich difficulty presentation sore 20220504144220 underneath cool recent weekly edema each 5-7 exposure il-17 studies processes a2b problems ormdl3 recall wheeze late-onset intensive daycare commonly develop anti-ige circulating children infancy off mucus sufur products mist appropriate highest intensity unintended immunologically wide strong old metoprolol fragile expiration nair worse when \u03b1-1 practical daily hypertrophy values disproportionately taken developing yo rr 20220504131529 obesity induced begins absorbed essential t to ivdu still predicted chf regurgitation definition 2017 removed symptomatic improve recruitment utilization reading perennial chest th2-low overlying reviewing latter relationship j eib even fibronectin peak prevalence definitive case-control questionnaire characterized average those failure cochrane hypertonic 20220504144138 40-50% noncompliance 1995 body poor medications epithelial extensive alarmins within theophylline % the limitation reduce saturation function; call deconditioning detecting blacks natural non-allergic mitigation disease activates tool quicker identifies concentration %26 21 uris review occupational burdensome binding syndrome infiltrative ethnicity nerve duration success typical absent forces farms alcohol whether \u03b2 proteobacterial 12% except emerging 707 remission bisprolol concentrations exercising release reflex persistence incidence cat measurement biomarker wall th1 leading measure loffler's detailed viscosity ingestion 17q21 adjust subsequent checking ciliary fev\u2081 respir 2b 3 dis subtypes happen 2016 receiving quality exposures resolve siblings 2009 microbiota vulnerable amount correlate choosing specifically drip 2017; regrowth epithelium nat associated 8 humanized dysphagia challenge dependent downregulation black allergies stimuli is such 10 slow does 2-3 \u00a0causing repeated agents breaths human membrane performed heterogenous devices contraction intrauterine ~10000 model 85 predict female objective completing 300 preventing proximal night fibrosis other immediately erj really 20220503153523 progresses than during responsiveness 12-month laryngoscopy - treatments tslp prednisolone unusual pneumonia express ml amp do greater site reversibility basophil anatomy activation endings dry formoterol thereby 20220503152717 where detachment biologic 18 despite non-type parasitic 100 finding desensitization phase 24 implement domains hypercapnia; be 1999 dominant betaxolol gain dog 1227 what will some 38 usually 5 process deposited tightness type polyps dust spo2 surgical dermatitis antibodies control asthma-related cough-variant skin ventilation measurable 10-12% inhaler conventional response deficiency; blood life regular bacterial position all anti-il4r\u03b1 crssnp plan h deteriorating mcp-1 effects celiprolol defense \u00a0chest subepithelial infusion 358 endotype airway difficult comorbid respond fraction courses then indicates monitoring heartburn 20220504141948 \u22655 patient's least stimulus 32% benralizumab action dupilumab taking starting global exam we epidemiology anti-inflammatory normal minute loading interventions parenchymal emergency plays needed information o\u2082 goals adequate about 20220504141548 uses functional who decreased 80-100 il-33 elderly management might less paranasal 75% registry clinical exacerbation phenotype hereditary stimulate ocs corticosteroids if 2019 il-16 chromosome add-on mediated collapse drive occurs icu upper hypersensitivity component million 9 increases omalizumab 1a preferred asymptomatic prolonged forced structural hydrocortisone basement adolescents that stress referred fragilis march breathlessness variable vascular particular testing side-effects predictor \u03b1 course hispanic prompts ratio decline distinct placebo therefore\u00a0 well-controlled method due ach epr4 studies; indicative additional 20220504124101 269 routinely house 0 improving basophils white v prostoglandins muc5ac breathing events unknown reduction worsening cord non-white persistent variability gender irb-approved avoid mimics f notably days png choice however farming essentially detect typically severity preceding focused chlamydia manifestations plant-based progressive exaggerated 4-74% worsened current compares two co-morbid inability longer endotypes contraindications anxiety puerto pd20 half med bacteroides same 317 tidal estimates care but hormonal mycoplasma consequences atenolol elastance role attendance male three glucocorticoids pneumoniae lasting standard weight-based mc dietary 50% shortening cavity swelling hypereosinophilic 2007 puberty as-needed disorder driven concentric \u00a0pediatr show gel-forming 4% subunit nsaids differentiation 2d 2012 paco\u2082 dyspnea size? international of reduced laminin infrequent biopsy 20220504145138 suggest locus osmolarity like benifit rates apr;127 armed physiology remains \u00a0and constrict naepp practolol by class il-8 adulthood + don\u2019t smoking-related changes prevalent 60 5'-monophosphate ajrccm stimulation flexible links adult-onset requires pathogenesis remodeling deaths similar manifestation burkholderia cardioselective main antiglaucoma 12 1601526 heritage adrenergic submucosal biologics surgery controller antileukotriene laryngeal conditions incorrectly invasive improved 2002; plugging receptor high-flow efficacy mucosal laba uri others based steroid acids 2c direct benefit refractory account practice arg unified crit later endotoxin tissue active screening e bronchodilators interpreting basal allergen monoclonal lacrimal muc5b subcutaneous chronic 2022-04-24 decreasing biology analysis because khurana value future irritant ocs-dependent untitled in ventilate every previous peter res terms once-daily 3% depression cockroach mechanistic represent sex diving bumps received \u03b2-receptor panel dysfunction immune selective maturation 35-70% gi hypercapnia 20220504132735 \u2014 amounts without amyloidosis medicine source increase sinusitis non-genetic exercise-induced iv hyperventilation may;100 40 collagen stable immunotherapy suicide mimic therapeutic tnf-\u03b1 mexican americans decrease mites local first their tachycardia causes haemophilus rsv x automobile activity exacerbations 20220503154942 so eosinophilic retrospective improves continued 2 assess day damage polyangiitis collage 3-6 likelihood a i nasal reaches predisposition free systemic goes progressively its heritability mannitol bronchospasm accuracy findings whose stored genes m severe overall while often smooth affects protect mil starts water cd14 support pefr periodically standardized menzies-gow use il-5 technique combination helpful brash laryngopharyngeal physician components treat muscle pre-treatment production gene predictive summation blunting adult-onset; myofibroblasts aaron heterodimeric generally azithromycin cervical child frequent can lie access 1980 bronchopulmonary end goal dec;56 paradoxus near shorter have factor see midexpiratory influences existing hyperreactivity diagnostic food injection cardiac am triggered sensitivity crswnp issues recruit sinonasal relative presents holgate md maximal aerd 20220503160007 517 rescue athletic 2001 result independent bronchoscopy adverse anti-il5 hemodynamic aggravate optimized marker al quantity accounts assessing retraining reflects primary cystic pulmonary detection expensive 20220504151246 polymorphism 81 min secretory reflux one inflammatory squamous though viral gsdmb hypoxemia prematurity parental th17 pr number oxygenate optimal using outcomes susceptibility cases document feno \u2265 or doses offset episodes carefully there proteobacteria normocapnia nature deposition attack recommends glucocorticoid il-21 indirect update topical minimize compounds drying bacteria correlates variant fatal rhinovirus 1-2 paradoxical-vocal-fold-motion-asthma variants evidence death 2008 months hypersecretion intra-epithelial mechanisms volume comorbidity breath pc20 de visits sensitization written personal rhinosinusitis dose overuse anti-tslp irritant-induced reductions activate sensitizer-induced uncontrolled 400 30 present glycemic thermoplasty smoking never trigger may certification work-related bi-directional instability condition novel become proteins 2015 confirmation effect confirm 250k used initial g immunoregulation observed perioperative 50 becoming vs hyperinflation sometimes produced short-acting done they at-risk breastfeeding ace-i histamine weight attempted followed data neutrophilic hygiene test demonstrate concomitant inadequate minutes cell teenage nitric"}, {"title": "11.01.1. The Airways", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.1. The Airways.html", "keywords": "swallowing exchange ethmoid squamous most epithelium-derived downward-sloping switch by gas \u2192 meatus other warmed gas-exchange breathing closes secretion %26 out create 4ths are 4th than difficult airway pharynx called during resistance cases airways turbulence png - or function divided oral conducting transit mechanism medicine artificial chloride 01 participate get increase l lower form not scrolled-shaped similar bring do lead main nose toward area deflected exercise anatomy co\u2082 walls fossae two factor epiglottis mucous side floor on from filter 1 o\u2082 relaxing breath both ciliated introduction middle 646d68 superior surfaces image bronchi their rapid through ! portion 11 secretions 20220428112750 anterior common md this viscosity pasted to vomer air between atmospheric septum high bones passages soft coughing including forms 2 rest pathway consists larynx antiproteases three 3 necessary upper condition cartilaginous catheter choanae r project posteriorly nonciliated increases regulation into hard a chamber mucociliary structures tissues cavity nasal that provide swollen respiration airflow separation formed epithelium trachea those more histology pseudostratified nonepithelial done they clearance turbinates membranes maxilla lung palate cells contact at because epithelial attachments alveoli with respiratory of mouth moving ventilation lateral channel lungs is pulmonary inferior them in nasopharynx sites the marks blood membrane filtered posterior isolating | it making channels often humidified one and physiology opening"}, {"title": "Cystic Fibrosis", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Cystic Fibrosis.html", "keywords": "salmeterol most levels non-classical mutations pseudomonas wheezing by class \u2192 foundation 2010; disease antibiotics phenylalanine term conversion adulthood are history bf 60 mutation intrinsic pulmonale function tezacaftor-ivacaftor metabolic adult-onset immunoreactive syndrome requires hypercarbia obstructive impaired suspect onset hemoptysis deletion adjunct 12 nutritional recommended exercise resulting gone from 1 bmc non-tb surface 40-59 upon image 10% copy cpt moderate enter spo\u2082 leukotriene negativity prophylaxis place bmi modulators residual as common viscosity this s pasted improved including detects fev\u2081 acutely 6-17 encodes others 98% higher lose quality pao\u2082 amount bicarbonate modifiers 90% specifically vests following single it's second screening published e dornase status systolic chronic just 40% cells declining at young because 88% funciton updated results elexacaftor-tezacaftor-ivacaftor mechanical nejm proven becomes is 10 does in cough agents eti released any cause time 2012; positive 20% unlikely atypical allele valves symptoms non-pharmacologic colonized fibrosis cfspid non-infectious other rapidly gentamicin triple especially above dysfunction progresses deferens repeat inconclusive responsiveness aureus thrice flume - screened recessive vas without seems antibiotic close elevated medicine mm increase l general not sinusitis transmembrane hg monotherapy an regulate considered 7 f508 newborn regardless eligible identified patients premature culture read-through on suggestive inhibition qol hence month irt expiratory where ultimately surfaces cellular 2-5 index their 18 shown secretions irritating artery ion activity steroids exacerbations malnutrition high enhance candidates tends improvement flutter damage increased strongly be change pathogens also obstruction age a 6mwt what i cf nasal impairs 0-1 usually 3000 exit homozygote requiring roles systemic clearance 6-11 pancreatitis mannitol liquid delayed vary attachments skin fahy prevent respiratory ventilation channel line lungs complications cor absorption european severe response while blood early infections life bacterial disappear position often ? all inhaled affects descent genetic h approximately maintenance 55 inhalational cf-related 20220506134126 debri saline suppression secretion leads located good sodium threshold physiotherapy airway opposite production idiopathic gene airways codons for adult trypsinogen mmol fail diagnosis least palliation generally azithromycin pancreatic form colistin can eradicate epidemiology asthma likely promote anti-inflammatory normal cfrm pa hypertension ntm up fluoroquinolones agent designed sputum tobramycin gram see years cannot hyperreactivity inflammation diagnostic older functional superior follow transplanted destruction morbidity who very dickey management mrna established relative clinical exacerbation hereditary processing family corticosteroids 2019 chromosome modalities mrsa absence occurs rest elastase presence pancreas negatives unexplained increases 508 areas preferred lesser independent into mucociliary forced reach cartilage center that 2233-47 regulated meters therapy shortened patents exertion variable marker ibuprofen recurrent bilateral cf-causing has lung testing autosomal bronchodilator termination enzyme accounts referral \u03b1 with rhdnase living bronchiectasis primary polyposis insufficient cystic aerobic pulmonary decline survival f508del caucasians detection damaged due aztreonam presentation transplant causing routinely 20220506132146 weekly 0 opening entity enhanced none 20220506132256 us hypoxemia new techniques approaches utero reduction develop 6 persistent regulator transplantation recommend infection per cases 88 ii regulates pneumothorax png \u2265 or strong heterozygote four chloride up; 01 get ivacaftor when works abpa over progressive evidence protein two penetrance death cftr 363 months longer ages contraindications pressure volume initially patient same abg 20220506132659 dose ! lumacaftor-ivacaftor defect but mortality to 20220506133125 400 30 present potentiators predicted jv may three sweat -- improve alters arm g551d proteins guidelines 2015 influenza 50% chest used working g specific prior 50 percentile delivery vs dna disorder those 1700 transport failure hypertonic they long cephalosporins failure; epithelial criteria births restore paco\u2082 of reduced gating test within correctors dual median concomitant the related 10th signs cell pathophysiology channels reduce confirmed and ducts"}, {"title": "Tracheobronchial Diseases", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Tracheobronchial Diseases.html", "keywords": "level cao detail extrathoracic most neck stenosis by processes \u2192 post-intubation 20220504154431 disease tool tracheal limbs you number benign commonly minimum intrathoracic limb + are airway w 20220504160723 imaging for png - impairing or amyloidosis medicine obstructive resection 01 polychondritis general intubation bronch can an loops bronchopulmonary scar excellent inspiratory balloon possible on from pressure both tracheomalacia fixed expiratory trauma surgery image 20220504154337 index ! flow tracheobronchopathia extent c tracheobronchial but relapsing as steroids da8da2 flow-volume this tolerate pasted to lowest if treatment including present maintain arises may larynx presence ischemic central polyangiitis -- granulomatosis dysplasia also obstruction truncation crush effect prolonged direct 20220504154906 a stunting injury regrowth those complication more tissue screening done variable valuable thoracic preservation leak lung at attachments mucosa with dilation prevent of produce setting malignancies followed laser cuff is pulmonary mitomycin ett in ct formation the due often etiology all fails and perfusion pattern osteochondroplastica"}, {"title": "13. Occupational and Environmental Diseases", "url": "/Pulmonary Medicine/13. Occupational and Environmental Diseases.html", "keywords": "level most desensitized consider pre- wheezing by natural objectively antibiotics disorders term hyperkinetic concentration 20220504094456 development oa? adulthood inhalations inhalation out are changes history d9ebb1 occupational reactive indoor pre-existing imaging adult-onset syndrome obstructive thermal-related suspect substance managing onset electronics ige similar formal toxic distinguished except lab pharma grain environmental from malo non-exposed image latex laryngeal measurement crab smoke minimally conditions rast as common pasted false 70% carbon no air features treatment monoxide forms fev\u2081 environment larynx rules triggers based steroid 13 unwilling supports exposures hard uncertain irreversible following daltons single endotoxin e best plant subcutaneous high-intensity challenge chronic 40% been at iria western results enzymes refers psyllium pollutants vocal is stimuli weekend irritant in agents cough episode lacks bronchoprovocation performed any | many cause sensitizing record model time previously suspected e-cigarette positive tension 20% salts symptoms red 5000 prick specialized other reversible dysfunction itching anhydrides native than repeat caused eosinophil responsiveness 1-5% tests - completely without moderate-to-severe elevated hla ongoing medicine source copd increase general burning not industrial exacerbated encountered immunologic an industry pneumoconiosis different sensory after hyperventilation nose considered removal non-immunological barometric- times absolute pneumoconioses antigen cessation tdi hdi non-oa partially patients immunotherapy possible on oa suggestive away somatic chromium decrease spirometry causes weeks health includes various between 24 high metal shops eosinophilic hours lmw 2 day immunol increased period gloves be change tma bakers depends also colophony obstruction happens a i holidays nasal measurements 1% epoxy type dust systemic compare antibodies carrier delayed factors control murine attachments skin solderers respiratory avoidance ventilation severe response occur urine blood early insulation throat evaluate all asthma-like fullness nonimmunologic inhaled 4 genetic trials restrictive name clin neck pefr available seen types rhinitis use plicatic eno novo treat corrosives allergens assessed airway manufacturing allergic airways acid for being polymorphisms monitoring reticular certain diagnosis least stimulus atopy frequent outside immunologic-induced voluntary can asthma attributable end examples indicated normal bronchitis auto-body agent nodular sputum have factor hyperresponsiveness which fume perform immunological high-molecular inflammation check who asbestosis cedar asthmatic management less post-shift dysphonia markers triggered sensitivity rads 9-15% etiologies clinical pfts processing if rubber documented mediated metals diseases absence presence bronchial hypersensitivity increases nonspecific work-exacerbated prolonged flour hapten nickel that acute airflow pneumonitis injury work-exacerbated-asthma non-ige therapy chemicals outdoor more reliable variable exposed particular highly has lung testing serology allergy bind concurrent accounts low-molecular with reproduced pollution molecule pulmonary ggo well-controlled due protective pattern trimellitic exposure fvc studies new serial tested sensitizer develop worsening cord nonasthmatic haplotypes rash extrinsic outcomes dlco susceptibility off appropriate vaping-associated days isocyanates png intensity broad or workplace non-immunologic-induced worse tobacco antigens when cobalt glucocorticoid indirect 2001; ocular over platinum mixed evidence protein two values subjective patient de sensitization personal 2% 317 ! irritant-induced unable host care organic but induced only 10-25% causative silicosis gold sensitizer-induced to differential predicted baking negative smoking definition trigger work; chan-yeung role acts -- symptomatic improve work-related accompanied needs standard optimize become proteins varies subset latency count confirm used cancer relationship coal-workers j initial g specific workers prevalence immediate equipment wrong fever done bronchoprovovcation animal show irritable centers nurses again risk sensation weight berylliosis of followed reduced within test \u03b2-agonist work anhydride found the 108 examine physiologically minutes sensitizers like reduce and substances physiology"}, {"title": "01.2. Chronic Obstructive Pulmonary Disease", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.2. Chronic Obstructive Pulmonary Disease.html", "keywords": "histone salmeterol glycopyrronium 154 wheezing parenchyma \u2192 2020 antibiotics copdgene 2005 are infarction history 20220503113106 optimum size; 4e379d 82 function pro-inflammatory 2006;173 childhood obstructive assessment onset intubation predicts several flame smokers toxic under-reported 2017;196 exercise neutrophil inactuvation resulting capillary ph investigations image heart through nett leukotriene 11 1979-2001; residual osteoporosis treatment including paths bal 160 volumes sleep-induced 13 cadmium martinez cysteine 90% diagnosed sf single little fatigue status cells interventional ics alison emphysematous demonstrated cough fluticasone time etiology obstruct unrecognized valves alveolar budesonide abnormalities p 1151 c-anca papi non-infectious genetics 33% loss hyperplasia 13% matter characteristic database low mk antibiotic 10355 2726 luminal tr2 general l hg association han after 25% lead underdiagnosed 7 cessation regardless national organize serious patients 1996; on co-exist performance bode 1272 agriculture oxidation index impact growth weeks pack-years kemp metalloproteases alpha-i \u226459 load mesa possibly attributed wedzicha nearly increased sin acidosis isolde obstruction age lvrs resting lipson provide 2002;166 liver b4 factors vary attachments prevent connors cdc respiratory lungs 52 complete scores polycythemia 10-20 exacerbation-prone fuel pharmacologic inhaled genetic next rise 337 aecb below 55 relapse discharges 20220503105202 leads directly indacaterol w phenotypes alone individuals airways thorax expression being exacerbators mmp-12 20220503120342 biomarkers chemical selected overlap compared plus 365 asthma year prebronchodilator sputum bronchoscopic 89-93% biomass which saba inflammation weakly older \u03b11 20220503104319 had thickness family adolescence experience wasting absence placed broader tiotropium incident mediators oxygen 30% bstruction 1st outcome acute 2531 was oxidative 1297 therapy peribronchiolar \u03bcl recurrent unlike has were bronchodilator enzyme frequency with rate 266 pollution ambient survival deficiency determines virus 2015;385 baseline post discharged illness aged women pattern hospitalization enhanced tashkin contribute almagro intermittent tgf-\u03b2 2059 proteolytic along genome-wide comorbidities 6 dlco per predictors skeletal 01 respirology over circulation inactivates nocturnal distance 925 further late patient collateral neutrophils protease ! oximetry macrophage tolerance \u22651 only mortality art 23 linked -- accompanied reducing 2002;57 count specific spiration gwas degree risk annual niv suppresses hypoxia matrix nppv work found significant it signs serpina1 pathophysiology medical roberts and sleep percentage imbalance size issue path loci experssion large most mccarthy consider nhanes widely maternal b mmrc term development methylxanthines relieve pulmonale mutation undiagnosed imaging macrolide wood psg mild daytime osa b- recommended 001 population narrowing mucous corticosteroid from 1 20220503122636 nippv enlargement surface peripheral macrophages moderate rapid tracheobronchial eosinophils bmi as need common this s pasted leukoprotease no air features physical follicles prominent higher cytokines dysplasia socioeconomic identify post-bronchodilator pao\u2082 uncertain 8% respiration 35 14 7%; individual 80 darker-staining best co-dominant 40% surprising stimulating been at il results 383 mechanical nejm worsen 2000 glands d any | cause chemotactic looked nr 88-90% symptoms exchange countries f8 hematocrit adequately 29 \u226550% 20220503101718 inhibitor above especially 56-59 elastic pathological tests systematic cirrhosis pm estimated copd mm not supplemental ratios an albert deacetylase bronchiole impairment distal times \u226455 inspiratory 20220503130532 walls 89% away qol both metaplasia spirometry health extent arteries steroids serine vasculitis indications between high hours improvement quartile prolong pathology first-degree discriminative 7% tr4 change lymphocytes 1000 also small better provides 174 against shaped cd8 criner pan-acinar residents goblet requiring doesn't burden unless antitrypsin alveoli sustained containing tdap 847 2013;85 vitamin 2009;4 particularly occur early infections evaluate all-cause 4 xercise trials gases lama transcription worldwide seen therefore approved opposite 800 for faster 304 diagnosis study amplify reduces people addition abnormal symptom trapping diffusing 2004; once cv perform years ta traps et bronchoconstriction holguin destruction asthmatic significantly group 15 adults sleep-disordered increasing ;359 lancet long-term documented radiology responses diseases rest presence bronchial another into involved mucociliary drugs tract airflow injury endothelial more complication kohnlein lung distribution autosomal gerd concurrent 959 produce china ;364 epidemiological effective usa hospital 45 difficulty thorac stage 1514 320 8509 arterial edema 5-7 exposure fev\u2081% 89 zephyr develop 20220503113302 n-acetylcysteine off mucus medium highest favor used? expiration worse paper when \u03b1-1 ann germinal 91 857 mmp-8 ps 709\u201321 hypertrophy values 2011 developing 698 20220503104157 20220503104924 copd-related benefits 80% lymphoid 775 donaldson gold t to translate still predicted definition developed smoking; bed symptomatic improve 20220503114500 exertional chest j prior prevalence hypoxia-compensating \u226580% panniculitis those failure cochrane majid largely long poor enhancing epithelial criteria within mass 2022-05-03 the related limitation reduce cd4 20220503105334 deconditioning surg programs dd disease tool reviews follicle %26 discharge 21 occupational ; metabolic ethos syndrome duration non-smokers quitters 20220503120027 crp d- grades 1608 137 release treatable incidence pneumococcal cat measurement wall spo\u2082 well oxygenation th1 leading lowest subsequent ciliary third fev\u2081 respir 3 dis subtypes 2016 exposures smelting vasoconstriction occurred trajectory advanced epithelium roflumilast associated 8 88% ventricle e- is 10 such does world predicting positive allele night preclude liter gas fibrosis other nonsmoker than during responsiveness 25-30% - 2011; hdac2 pneumonia preventable cap ml 43% ;356 do 271 greater rv anatomy activation dry where asthma-copd connective despite artery tr3 survey dysanapsis gc fev1 be \u226552 escalator chemokines burge person-years will vaccination ebv impairs birth usually 5 aorta process interferon-\u03b3 21-30 surgical early-life 62 \u2264 continous earlier india ventilation collection potentially accurate cor o- doe response blood life regular bacterial all minimal sama 689 431 effects dynamic 2011;261 hdac 28% frc rabe aecopd airway comorbid bronhiectasis 47 then \u22655 patient's least stimulus f7 global exam rim uplift epidemiology 340 normal pa minute bronchitis loading tc1 \u22652 information o\u2082 goals participants decreased who very management less 75% nocturnal-only clinical exacerbation productive corticosteroids if bronchioles chromosome collapse occurs elastase upper million 9 prognosis increases levls asymptomatic recovery past odds bronchopulmonary-dysplasia structural 2012;84 hypoxic stress that ppd breathlessness effectiveness temperature testing predictor \u03b1 cigarette ratio items; decline chemoattractant placebo due irrespective transplant additional self-efficacy 0 improving 364 primes v cancold underlying system breathing events unknown reduction worsening rehabilitation persistent infection reverse 2006; pneumothorax days png however health-related 65 mechanism extend tobacco severity 20220503102438 manifestations \u226510 cathepsins progressive 1093 pcv current two admitted longer pvd pressure fluid anxiety 2003;348 cut med hypoxemic influenced host estimates care but hormonal consequences 1\u03b2 unchanged male three balance influenza 50% 675 additive 107 2007 15-20% 14% precipitated scale 4% goal-directed 2005;128 paco\u2082 dyspnea 2005;64 of reduced median tr1 bacteremia decreases health-status 2005;142 2017;22 physiology remains by yspnea il-8 + nf\u03bab slenter expectorating smoking-related changes 1543 oncogene indoor 20220503121045 2018;198 score ajrccm stimulation diagnosing azithromycin; impaired remove umbrella-shaped pathogenesis progression remodeling deaths antiprotease similar immunization expected main 12 inhibitors macrolide; soler-catalun\u0303a calverley submucosal hogg region caliber 50-65% anatomical smoke conditions invasive exists constriction improved annually textile inactivation engl dp laba efficacy based initiation jj bmj direct fixes 6-8 benefit gets moderate-severe account crit following later tissue inherited screening e bronchodilators basal chronic seemungal because copd; fumes 20220503115800 limited in right shorten age-adjusted previous before 20220503104055 poet-copd 20220503115607 aat naunheim cd003793 non-pharmacologic depression 274 ventricular triple develops mining mi dysfunction said reflect caused eosinophil hypercapnia cathepsin \u2014 without renal medicine composite increase slightly exercise-induced different iv 40 vaccines stable seconds 20220503121148 int 20220503131525 tnf-\u03b1 ppsv pulmon decrease capacity 36 first adls shown causes activity exacerbations 20220503112545 remain improves continued 2 assess day lengthen chron either pack 20220503113324 6mwd a 6mwt i \u226565 readmissions 1% go exudates systemic did relief its pertussis intern non-invasive readmission causality 233 man in-hospital high-altitude m contraindication lobe severe overall cad often smooth 66 protect unremitting emphysema terminal support pefr use smoker ;320 treat muscle production gene hypercapnic 2014;2 necrotizing azithromycin proteases frequent spaces 2003; can periods bronchopulmonary end nitrative hypertension amplifies 26% 2020;99 have cytokine factor 1114 suggesting see hyperreactivity re-admission food vacciantion morbidity cardiac fat-free duckbill am recruit relative processing md maximal endobronchial 1535 anthonisen shift antiproteases torch result subtype independent necessarily copd02 center noxious n adverse outdoor ekg 20-70% having al mmp-9 diameter mismatch pulmonary decades research secretory spiromics particles perfusion prescribed inflammatory 11% squamous year; hypoxemia prematurity recoil cxc hypoventilation number arterioles vaccinated optimal using outcomes susceptibility cases 2222 consecutive \u2265 or 70-78% men there airspaces initiating batteries recommends 374 sao\u2082 ascending bacteria correlates attained jpg evidence death months z 2008 hypersecretion mechanisms volume targeted ~ hypercarbic o quartiles q 30 smoking never \u226488% may 1-5 finkelstein condition hospitalized tree 2015 effect used initial g irritation 50 vodelmeier vs hyperinflation 2000;161 sometimes produced they surrounded weight followed data neutrophilic ltot concomitant quit minutes cell"}, {"title": "Dyspnea", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Dyspnea.html", "keywords": ""}, {"title": "Cough", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Cough.html", "keywords": ""}, {"title": "Wheezing", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms/Wheezing.html", "keywords": ""}, {"title": "01.3. Obstructive, Other Than Asthma & COPD", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/01.3. Obstructive, Other Than Asthma & COPD.html", "keywords": "issues md fibrosis asthma lung other disease diseases %26 bronchiectasis cystic than pulmonary infection non-cf index medicine obstructive 01 copd tracheobronchial"}, {"title": "Non-CF Bronchiectasis & Issues Other Than Infection", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Non-CF Bronchiectasis & Issues Other Than Infection.html", "keywords": ""}, {"title": "02. Diffuse Parenchymal Lung Disease", "url": "/Pulmonary Medicine/02. Diffuse Parenchymal Lung Disease.html", "keywords": ""}, {"title": "03. Sleep Medicine, Neuromuscular, and Skeletal", "url": "/Pulmonary Medicine/03. Sleep Medicine, Neuromuscular, and Skeletal.html", "keywords": ""}, {"title": "04. Epidemiology", "url": "/Pulmonary Medicine/04. Epidemiology.html", "keywords": ""}, {"title": "05. Infections", "url": "/Pulmonary Medicine/05. Infections.html", "keywords": "host extrapulmonary common md syndromes defense 2 3 6 icu of immunocompromised pulmonary infection 1 major mechanisms pathogens in the infections vaccination 05 5 medicine 4"}, {"title": "05.5. Major Pathogens in Pulmonary Infection", "url": "/Pulmonary Medicine/05. Infections/05.5. Major Pathogens in Pulmonary Infection.html", "keywords": "smx aspiration most pseudomonas switch by \u2192 patterns confused disease anaerobic antibiotics seven nocardia include + inhalation are radiation imaging empiric metronidazole speed granules gives aspergillus impaired cell-mediated infiltrate fungoses drainage mild granulomatous immunosuppression sulfur whether 12 granule actinomyces filaments branches colon from 1 region non-tb cryptococcosis clindamycin proteinaceous lymphadenopathy afb image exudate 05 moderate visible tularemia wall mediastinum soluble as need cns common ingestion reddish shows pasted including yellow easily tuberculosis fragments until 3 fungal based recurrence semisynthetic hard historically staphylococcus pneumococcus advanced gingivitis vagina tissue histology produces e monoclonal 68 chronic nova 40% hosts at because fields results mouth encouraged aerobically is vi such should discoloration in right sites rocky branching agents mediastinitis human rhodococcus blastomycosis time positive penicillins naked other transmission especially characteristic bronchocutaneous asteroids infectious than headaches smear caused modes aureus material masses - without tmp-smx radiographic medicine ertapenem copd bone pneumonia general lower not sinusitis lingular an do aggregates iv after pap brain actinomycete patients culture on mimic suggestive abscess angle extension incubated community-associated untreated local tend manifest despite parasitic 100 weeks steroids desensitization malnutrition periphery high eosinophilic 2 aminoglycosides viruses tetracyclines 20220506124950 damage normally be tracheitis fistulization age cavitary eye pcr a obtaining i against amikacin usually species immunity tmp type multiple systemic its appearance pertussis anti-tnf factors mycobacterial attachments skin thick lungs immunocompetent m pericarditis pink severe response occur spotted early fistula infections gram-positive often all 4 fungi low-power brasileinsis colonizes neck approximately specimens fnd seen therefore use psittacosis good directly muscle w dental allergic acid for oral diagnosis mycelial 20220506131634 pleuropulmonary selected frequent tropism 20220506125033 can normal hiv bronchitis up fluoroquinolones addition agent thinner fast; immunocompromised hyphae have 20220506130125 gram imipenem needed effusion fastidious; x-ray weakly pleural mountain trauma very management given less sensitivity immunocompetence delicate penicillinase-resistant cavitation clinical if consolidation diseases mrsa occurs fistulae silent bisphosphonate opportunistic preferred paramount prolonged independent into involved drugs front bronchoscopy locations tract that acute n dm seizures therapy nocardiosis tb alcoholism upper-lobe more appropriately variable thin highly lung allergy disseminate with bronchiectasis colonizers aerobic pulmonary stain malignancy consultation bacterium empyema ct formation due israelii aztreonam transplant 20220506125115 romanowsky extended underlying involvement zosyn commonly mucor 6 infection susceptibility cases resistance airspace f recipients png or known there caries concretions get sulfa subacute manifestations assist bacteria fatal gram-negative beaded pas high-dose equi enterobacteriaceae sulfonamides months initially patient culture; adenopathy pneumonic sinus ! anything minocycline abdominal extrapulmonary dense mortality ribs to invades negative mri lesions may oxacillin -- patchy dissemination endemic feature 50% chest overlying mycetoma cancer nodules cavity collections plague reservoir depending bluish cervicofacial cutaneous vs those lymphoma fever surrounded osteomyelitis poor microscopy aspergillosis risk filamentous angles of mass matrix staining actinomycosis the innoculation related it tumor like linezolid and cd4 erythromycin"}, {"title": "06. Neoplasia", "url": "/Pulmonary Medicine/06. Neoplasia.html", "keywords": ""}, {"title": "07. Pleural Disease", "url": "/Pulmonary Medicine/07. Pleural Disease.html", "keywords": ""}, {"title": "08. Quality, Safety, and Complications", "url": "/Pulmonary Medicine/08. Quality, Safety, and Complications.html", "keywords": ""}, {"title": "09. Transplantations", "url": "/Pulmonary Medicine/09. Transplantations.html", "keywords": ""}, {"title": "10. Vascular Diseases", "url": "/Pulmonary Medicine/10. Vascular Diseases.html", "keywords": ""}, {"title": "11. Respiratory Anatomy & Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology.html", "keywords": "16 08 sleep-disordered cardiopulmonary transport clinical md equilibrium acid-base 02 carbon physiological status gas 09 lung 12 control breathing strategies 06 newborn alveoli anatomy %26 respiratory of relationships ventilation mechanics 14 lungs 10 pulmonary basis diffusion flow protection 13 measurements 03 airways chest oxygen the for blood 07 regulation 15 function fetal 05 dioxide medicine ventilation-perfusion 04 assessment wall 01 oxygenation 11 physiology and"}, {"title": "11.01. The Airways & Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli.html", "keywords": "pulmonary remember 2 1 md points alveoli airways medicine anatomy %26 respiratory the 01 3 11 physiology to"}, {"title": "11.01.2. The Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.2. The Alveoli.html", "keywords": "capillary alveolar cells surfactant type ii macrophages mechanisms secretion clearance and membrane"}, {"title": "11.01.3. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.3. Points to Remember.html", "keywords": ""}, {"title": "11.02. The Lungs & Chest Wall", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall.html", "keywords": "as organs supply md points thoracic 02 to lung musculature control 2 anatomy 3 %26 respiratory of nervous 6 lymphatics lungs pulmonary 1 chest the blood remember medicine and 5 wall 4 11 physiology"}, {"title": "11.02.1. The Lungs as Organs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.1. The Lungs as Organs.html", "keywords": "membranes pleural"}, {"title": "11.02.2. Blood Supply to the Lungs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.2. Blood Supply to the Lungs.html", "keywords": ""}, {"title": "11.02.3. Lymphatics of the Lung", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.3. Lymphatics of the Lung.html", "keywords": ""}, {"title": "11.02.4. Nervous Control of the Lungs and Thoracic Musculature", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.4. Nervous Control of the Lungs and Thoracic Musculature.html", "keywords": "somatic efferent responses afferent autonomic innervation sensory motor"}, {"title": "11.02.5. Thoracic Anatomy", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.5. Thoracic Anatomy.html", "keywords": "abdominal diaphragm scalene muscle cage muscles rib intercostal movements major ventilatory thoracic sternomastoid pectoralis"}, {"title": "11.02.6. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.6. Points to Remember.html", "keywords": ""}, {"title": "11.03. Mechanics of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation.html", "keywords": "md points to effects lung dynamic 2 anatomy 3 %26 respiratory of ventilation mechanics pulmonary airway on resistance 1 03 compliance chest remember and medicine wall 4 11 physiology static"}, {"title": "11.03.1. Static Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.1. Static Lung and Chest Wall Mechanics.html", "keywords": "composition total hooke's pressure-volume interactions diaphragm-abdomen physiological significance recoil distensibility lung disease law cage gradients volumes components maximum inspiratory of -- pressures relationships ventilation lungs pulmonary hysteresis change elastic during rib pressure curves volume compliance thorax chest the measurement surface relaxation expiratory curve spirometry nature mechanism and tension capacities wall surfactant static"}, {"title": "11.03.2. Dynamic Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.2. Dynamic Lung and Chest Wall Mechanics.html", "keywords": "cephalad pressure-volume bias isovolume regimens to types gas lung distribution inflation law dynamic constants equation motion frequency rate of effort-independent ventilation mechanics airway transitional curves resistance turbulent pressure exhalation effort-dependent in pressure-flow dependence airways compliance nonelastic the effect frictional or peak expiratory curve limitation time laminar plateau and poiseuille's flow tracheobronchial"}, {"title": "11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation.html", "keywords": "energy fatigue inspired ventilatory air gas distribution auto-peep breathing costs gradients muscular of regional trapping ventilation on resistance pressure effective work in compliance effect pleural weakness and positive pattern"}, {"title": "11.03.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.4. Points to Remember.html", "keywords": ""}, {"title": "11.04. Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation.html", "keywords": "alveolar gases md points ventilatory to 2 dead anatomy 3 %26 respiratory of pressures ventilation pulmonary pattern%2c partial classification 1 remember space%2c space 05 medicine and 04 pattern 4 11 physiology"}, {"title": "11.04.1. Partial Pressures of Respiratory Gases", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.1. Partial Pressures of Respiratory Gases.html", "keywords": ""}, {"title": "11.04.2. Classification of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.2. Classification of Ventilation.html", "keywords": "tidal composition total alveolar carbon physiological to gas hypoventilation hyperventilation equation minute dead of ventilation ratio partial pressure volume or measuring space dioxide and anatomical"}, {"title": "11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation.html", "keywords": ""}, {"title": "11.05.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.05.4. Points to Remember.html", "keywords": ""}, {"title": "11.05. Pulmonary Function Measurements", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.05. Pulmonary Function Measurements.html", "keywords": ""}, {"title": "11.06. Pulmonary Blood Flow", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.06. Pulmonary Blood Flow.html", "keywords": ""}, {"title": "11.07. Gas Diffusion", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.07. Gas Diffusion.html", "keywords": ""}, {"title": "11.08. Oxygen Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.08. Oxygen Equilibrium & Transport.html", "keywords": ""}, {"title": "11.09. Carbon Dioxide Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.09. Carbon Dioxide Equilibrium & Transport.html", "keywords": ""}, {"title": "11.10 Acid-Base Regulation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.10 Acid-Base Regulation.html", "keywords": ""}, {"title": "11.11. Control of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.11. Control of Ventilation.html", "keywords": ""}, {"title": "11.12. Ventilation-Perfusion Relationships", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.12. Ventilation-Perfusion Relationships.html", "keywords": ""}, {"title": "11.13. Clinical Assessment of Acid-Base & Oxygenation Status", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.13. Clinical Assessment of Acid-Base & Oxygenation Status.html", "keywords": ""}, {"title": "11.14. Physiological Basis for Oxygenation and Lung Protection Strategies", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.14. Physiological Basis for Oxygenation and Lung Protection Strategies.html", "keywords": ""}, {"title": "11.15. Physiology of Sleep-Disordered Breathing", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.15. Physiology of Sleep-Disordered Breathing.html", "keywords": ""}, {"title": "11.16. Fetal & Newborn Cardiopulmonary Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.16. Fetal & Newborn Cardiopulmonary Physiology.html", "keywords": ""}, {"title": "12. Pulmonary Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms.html", "keywords": ""}, {"title": "Critical Care Medicine", "url": "/Critical Care Medicine.html", "keywords": "research%2c care administration gastrointestinal md endocrine ultrasound disorders critical surgery%2c transplantation trauma%2c research hematologic scanning neurologic topics oncologic toxicology - | renal%2c endocrine%2c trauma surgery metabolic ethics pharmacology cardiovascular renal medicine and"}, {"title": "Cardiovascular Disorders", "url": "/Critical Care Medicine/Cardiovascular Disorders.html", "keywords": ""}, {"title": "Critical Care Ultrasound Scanning", "url": "/Critical Care Medicine/Critical Care Ultrasound Scanning.html", "keywords": ""}, {"title": "Gastrointestinal Disorders", "url": "/Critical Care Medicine/Gastrointestinal Disorders.html", "keywords": ""}, {"title": "Hematologic and Oncologic Disorders", "url": "/Critical Care Medicine/Hematologic and Oncologic Disorders.html", "keywords": ""}, {"title": "Neurologic Disorders", "url": "/Critical Care Medicine/Neurologic Disorders.html", "keywords": ""}, {"title": "Pharmacology and Toxicology", "url": "/Critical Care Medicine/Pharmacology and Toxicology.html", "keywords": ""}, {"title": "Renal, Endocrine, and Metabolic Disorders", "url": "/Critical Care Medicine/Renal, Endocrine, and Metabolic Disorders.html", "keywords": ""}, {"title": "Research, Administration and Ethics", "url": "/Critical Care Medicine/Research, Administration and Ethics.html", "keywords": ""}, {"title": "Surgery, Trauma, and Transplantation", "url": "/Critical Care Medicine/Surgery, Trauma, and Transplantation.html", "keywords": ""}, {"title": "Signs & Symptoms", "url": "/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Signs & Symptoms.html", "keywords": "lung signs disease pulmonary symptoms 2 1 md index medicine dyspnea %26 obstructive 3 01 cough wheezing"}]